Use of D/C/F/TAF With Neurologic/Psychiatric Comorbidities: AMBER Subgroup Analysis
CROI 2020 March 8-11
Reported by Jules Levin
Keith Dunn,1,* Richard Bruce Simonson,1 Donghan Luo,2 Jiyun Cai,3 David Anderson1
1Janssen Scientific Affairs, LLC, Titusville, NJ; 2Janssen Research & Development, LLC, Titusville, NJ; 3Janssen Research & Development, LLC, Spring House, PA.
